Gender effects of the COMT Val158Met genotype on verbal fluency in healthy adults
- Authors:
- Marcio Gerhardt Soeiro‑De‑Souza
- Danielle Soares Bio
- Denise Petresco David
- Giovani Missio
- Bruno Lima
- Fernando Fernandes
- Rodrigo Machado‑Vieira
- Ricardo Alberto Moreno
-
Affiliations: Mood Disorders Unit GRUDA, Department and Institute of Psychiatry, School of Medicine, University of São Paulo (HC‑FMUSP), São Paulo, Brazil, Laboratory of Neuroscience LIM‑27, Department and Institute of Psychiatry, School of Medicine, University of São Paulo (HC‑FMUSP), São Paulo, Brazil - Published online on: July 1, 2013 https://doi.org/10.3892/mmr.2013.1564
- Pages: 837-844
This article is mentioned in:
Abstract
 |
|
Murphy DG, DeCarli C, McIntosh AR, Daly E, Mentis MJ, Pietrini P, et al: Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry. 53:585–594. 1996. View Article : Google Scholar | |
|
Goldstein JM, Seidman LJ, Horton NJ, Makris N, Kennedy DN, Caviness VS Jr, et al: Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex. 11:490–497. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
De Vries GJ: Minireview: Sex differences in adult and developing brains: compensation, compensation, compensation. Endocrinology. 145:1063–1068. 2004.PubMed/NCBI | |
|
Harrison PJ and Tunbridge EM: Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology. 33:3037–3045. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Barnett JH, Heron J, Ring SM, Golding J, Goldman D, Xu K and Jones PB: Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry. 164:142–149. 2007.PubMed/NCBI | |
|
O'Hara R, Miller E, Liao CP, Way N, Lin X and Hallmayer J: COMT genotype, gender and cognition in community-dwelling, older adults. Neurosci Lett. 409:205–209. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Herlitz A, Nilsson LG and Bäckman L: Gender differences in episodic memory. Mem Cognit. 25:801–811. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
van Exel E, Gussekloo J, de Craen AJ, Bootsma-van der Wiel A, Houx P, Knook DL and Westendorp RG: Cognitive function in the oldest old: women perform better than men. J Neurol Neurosurg Psychiatry. 71:29–32. 2001. | |
|
Halari R, Hines M, Kumari V, Mehrotra R, Wheeler M, Ng V and Sharma T: Sex differences and individual differences in cognitive performance and their relationship to endogenous gonadal hormones and gonadotropins. Behav Neurosci. 119:104–117. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
van Hooren SA, Valentijn AM, Bosma H, Ponds RW, van Boxtel MP and Jolles J: Cognitive functioning in healthy older adults aged 64–81: a cohort study into the effects of age, sex, and education. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 14:40–54. 2007. | |
|
Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al: Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet. 75:807–821. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wayment HK, Schenk JO and Sorg BA: Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition. J Neurosci. 21:35–44. 2001.PubMed/NCBI | |
|
Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D and Karayioegou M: Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA. 95:9991–9996. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ and O'Donovan MC: A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet. 73:152–161. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Tunbridge E, Burnet PW, Sodhi MS and Harrison PJ: Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Synapse. 51:112–118. 2004. View Article : Google Scholar | |
|
Dempster EL, Mill J, Craig IW and Collier DA: The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression. BMC Med Genet. 7:102006. View Article : Google Scholar : PubMed/NCBI | |
|
Tunbridge EM, Lane TA and Harrison PJ: Expression of multiple catechol-o-methyltransferase (COMT) mRNA variants in human brain. Am J Med Genet B Neuropsychiatr Genet. 144B:834–839. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Tunbridge EM, Harrison PJ and Weinberger DR: Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 60:141–151. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Boudíková B, Szumlanski C, Maidak B and Weinshilboum R: Human liver catechol-O-methyltransferase pharmacogenetics. Clin Pharmacol Ther. 48:381–389. 1990. | |
|
Fähndrich E, Coper H, Christ W, Helmchen H, Müller-Oerlinghausen B and Pietzcker A: Erythrocyte COMT-activity in patients with affective disorders. Acta Psychiatr Scand. 61:427–437. 1980. | |
|
Floderus Y and Wetterberg L: The inheritance of human erythrocyte catechol-O-methyltransferase activity. Clin Genet. 19:392–395. 1981. View Article : Google Scholar : PubMed/NCBI | |
|
Philippu G, Hoo JJ, Milech U, Argarwall DP, Schrappe O and Goedde HW: Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychoses. Psychiatry Res. 4:139–146. 1981. View Article : Google Scholar : PubMed/NCBI | |
|
Fitzgerald GA, Hamilton CA, Jones DH and Reid JL: Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man. Clin Sci (Lond). 58:423–425. 1980.PubMed/NCBI | |
|
Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL and Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 6:243–250. 1996. View Article : Google Scholar | |
|
Weinshilboum RM, Otterness DM and Szumlanski CL: Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol. 39:19–52. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al: Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 98:6917–6922. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, et al: Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry. 59:662–663. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Bilder RM, Volavka J, Lachman HM and Grace AA: The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology. 29:1943–1961. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Diamond A, Briand L, Fossella J and Gehlbach L: Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry. 161:125–132. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, et al: Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry. 11:867–877. 7972006. View Article : Google Scholar : PubMed/NCBI | |
|
Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD and Robbins TW: Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci. 20:RC652000.PubMed/NCBI | |
|
Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ and Williams GV: Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl). 174:3–16. 2004.PubMed/NCBI | |
|
Caldú X, Vendrell P, Bartrés-Faz D, Clemente I, Bargalló N, Jurado MA, et al: Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage. 37:1437–1444. 2007.PubMed/NCBI | |
|
Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM and Gilliam TC: Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry. 58:901–907. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R and Nilsson LG: COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behav Genet. 34:533–539. 2004.PubMed/NCBI | |
|
de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R and Nilsson LG: Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. J Cogn Neurosci. 17:1018–1025. 2005.PubMed/NCBI | |
|
Barnett JH, Scoriels L and Munafò MR: Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry. 64:137–144. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Dennis NA, Need AC, LaBar KS, Waters-Metenier S, Cirulli ET, Kragel J, et al: COMT val108/158 met genotype affects neural but not cognitive processing in healthy individuals. Cereb Cortex. 20:672–683. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Solís-Ortiz S, Pérez-Luque E, Morado-Crespo L and Gutiérrez-Muñoz M: Executive functions and selective attention are favored in middle-aged healthy women carriers of the Val/Val genotype of the catechol-o-methyltransferase gene: a behavioral genetic study. Behav Brain Funct. 6:672010.PubMed/NCBI | |
|
Soeiro de Souza MG, Machado-Vieira R, Soares Bio D, Do Prado CM and Moreno RA: COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder. Bipolar Disord. 14:554–564. 2012.PubMed/NCBI | |
|
Zahrt J, Taylor JR, Mathew RG and Arnsten AF: Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci. 17:8528–8535. 1997.PubMed/NCBI | |
|
Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ and Robbins TW: Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci. 20:1208–1215. 2000.PubMed/NCBI | |
|
Arnsten AFT and Li BM: Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry. 57:1377–1384. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59(Suppl 20): 22–33; quiz 34–57. 1998.PubMed/NCBI | |
|
Strauss E, Sherman EMS and Spreen O: A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. 3rd edition. Oxford University Press, Inc; New York, NY: 2006 | |
|
Wechsler D: Wechsler Abbreviated Scale of Intelligence. The Psychological Corporation: Harcourt Brace and Company; New York, NY: 1999 | |
|
Wechsler D: Wechsler Adult Intelligence Scale-Revised. The Psychological Corporation; San Antonio, TX: 1981 | |
|
Lezak MD: Neuropsychological Assessment. Oxford University Press, Inc; New York, NY: 2004 | |
|
Laitinen J, Samarut J and Hölttä E: A nontoxic and versatile protein salting-out method for isolation of DNA. Biotechniques. 17:316318320–322. 1994.PubMed/NCBI | |
|
Clark L, Cools R and Robbins TW: The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning. Brain Cogn. 55:41–53. 2004. View Article : Google Scholar | |
|
Kimberg DY, D'Esposito M and Farah MJ: Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport. 8:3581–3585. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan F, et al: Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA. 100:6186–6191. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Sprague RL and Sleator EK: Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior. Science. 198:1274–1276. 1977. View Article : Google Scholar : PubMed/NCBI | |
|
Cousins DA, Butts K and Young AH: The role of dopamine in bipolar disorder. Bipolar Disord. 11:787–806. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang H, Xie T, Ramsden DB and Ho SL: Human catechol-O-methyltransferase down-regulation by estradiol. Neuropharmacology. 45:1011–1018. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Cohn CK and Axelrod J: The effect of estradiol on catechol-O-methyltransferase activity in rat liver. Life Sci I. 10:1351–1354. 1971. View Article : Google Scholar : PubMed/NCBI | |
|
Lindamer LA, Lohr JB, Harris MJ and Jeste DV: Gender, estrogen, and schizophrenia. Psychopharmacol Bull. 33:221–228. 1997.PubMed/NCBI | |
|
Halbreich U: Role of estrogen in postmenopausal depression. Neurology. 48(Suppl 7): S16–S19. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Colzato LS, Hertsig G, van den Wildenberg WP and Hommel B: Estrogen modulates inhibitory control in healthy human females: evidence from the stop-signal paradigm. Neuroscience. 167:709–715. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gasbarri A, Pompili A, d'Onofrio A, Cifariello A, Tavares MC and Tomaz C: Working memory for emotional facial expressions: role of the estrogen in young women. Psychoneuroendocrinology. 33:964–972. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Andrewes D: Neuropsychology From Theory to Practice. Psychology Press; New York, NY: 2001 | |
|
Devinsky O and D'Esposito M: Neurology of Cognitive and Behavioral Disorders. Oxford University Press; New York, NY: 2004 | |
|
Darby D and Walsh KW: Walsh's Neuropsychology: A Clinical Approach. 5th edition. Elsevier Churchill Livingstone; Edinburgh: 2005 | |
|
Ruff RM, Light RH, Parker SB and Levin HS: Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol. 11:329–338. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Henry JD and Beatty WW: Verbal fluency deficits in multiple sclerosis. Neuropsychologia. 44:1166–1174. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Bolla KI, Lindgren KN, Bonaccorsy C and Bleecker ML: Predictors of verbal fluency (FAS) in the healthy elderly. J Clin Psychol. 46:623–628. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, et al: Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort Study. Percept Mot Skills. 73:539–550. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Libon D, David J, Glosser G, Malamut BL, Kaplan E, Goldberg E, et al: Age, executive functions, and visuospatial functioning in healthy older adults. Neuropsychology. 8:38–43. 1994. View Article : Google Scholar | |
|
Tombaugh TN, Kozak J and Rees L: Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 14:167–177. 1999.PubMed/NCBI | |
|
Ruff RM, Allen CC, Farrow CE, Niemann H and Wylie T: Figural fluency: differential impairment in patients with left versus right frontal lobe lesions. Arch Clin Neuropsychol. 9:41–55. 1994. View Article : Google Scholar | |
|
Miller BL and Cummings JL: The Human Frontal Lobes: Functions and Disorders. 2nd edition. The Guilford Press; New York, NY: 2007 |
